Wegovy Maker Challenges Weight-Loss Drug Copycats Amidst Telehealth Boom | Oprah Winfrey on Weight Loss: Obesity as a Disease and Finding "Enough" | Wave Life Sciences' RNA Obesity Shot Shows Promising Results | Eli Lilly Cuts Zepbound Weight Loss Drug Prices | Novo Nordisk Offers Discount on Ozempic and Wegovy | Meghan Trainor Faces Backlash After Weight Loss Transformation | Savannah Chrisley Aims to Lose 25 Pounds with Weight-Loss Medication | Weight-Loss Drug Boom in India: Risks and Revolution | Wegovy Maker Challenges Weight-Loss Drug Copycats Amidst Telehealth Boom | Oprah Winfrey on Weight Loss: Obesity as a Disease and Finding "Enough" | Wave Life Sciences' RNA Obesity Shot Shows Promising Results | Eli Lilly Cuts Zepbound Weight Loss Drug Prices | Novo Nordisk Offers Discount on Ozempic and Wegovy | Meghan Trainor Faces Backlash After Weight Loss Transformation | Savannah Chrisley Aims to Lose 25 Pounds with Weight-Loss Medication | Weight-Loss Drug Boom in India: Risks and Revolution
The market for weight-loss drugs is heating up as Novo Nordisk, the maker of Wegovy, takes legal action against telehealth companies like Hims & Hers for offering compounded versions of its popular medication. This comes as analysts see a p...
Image via USA Today
GLP-1 wars: Wegovy maker challenges knock-off weight loss drug companies
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
Yanuki
